ID 211385268 · FY 2017–2024 · 8 years
GM Pharmaceuticals LLC (GMP) is Georgia's largest pharmaceutical manufacturer, producing ~140 brands across 230+ dosage forms at its Ponichala (Tbilisi) plant — the largest pharma facility in the South Caucasus. Exports across the CIS with 600+ employees.
curated 2026-06-03gmpharma.comyell.ge
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 94,259 | 105,923 | 123,065 | 135,929 | 183,285 | 191,099 | 130,729 | 184,906 | +10.1% |
| Total COGS | -24,560 | -29,377 | -36,173 | -41,004 | -61,327 | -72,367 | -48,358 | -62,907 | +14.4% |
| Gross Profit | 69,699 | 76,545 | 86,892 | 94,926 | 121,958 | 118,732 | 82,371 | 122,000 | +8.3% |
| Gross Margin | 73.9% | 72.3% | 70.6% | 69.8% | 66.5% | 62.1% | 63.0% | 66.0% | |
| Total Operating Expenses | -32,646 | -42,867 | -53,368 | -54,457 | -61,503 | -58,329 | -70,396 | -64,392 | +10.2% |
| EBITDA | 37,053 | 33,678 | 33,524 | 40,469 | 60,455 | 60,403 | 11,975 | 57,608 | +6.5% |
| EBITDA Margin | 39.3% | 31.8% | 27.2% | 29.8% | 33.0% | 31.6% | 9.2% | 31.2% | |
| Total D&A | -1,423 | -1,809 | -2,760 | -2,748 | -3,159 | -3,493 | -3,343 | -3,231 | +12.4% |
| EBIT / Operating Income | 35,630 | 31,869 | 30,764 | 37,720 | 57,296 | 56,910 | 8,632 | 54,377 | +6.2% |
| Total Interest Income | 417 | 1,145 | 0 | 0 | 485 | 1,051 | 2,010 | 3,320 | +34.5% |
| Total Interest Expense | -638 | -103 | -449 | -456 | -272 | -243 | -285 | -145 | -19.1% |
| Total Other Income | -2,119 | 89 | 1,008 | 4,591 | -4,845 | -15,594 | -3,259 | 2,783 | nmf |
| Profit Before Tax | 33,289 | 33,000 | 31,323 | 41,855 | 52,664 | 42,124 | 7,098 | 60,335 | +8.9% |
| Total Income Tax | 0 | 0 | -316 | -805 | -1,107 | -3,891 | 0 | 0 | +130.8% |
| Net Profit / (Loss) | 12,560 | 29,491 | 27,515 | 39,419 | 50,872 | 37,046 | 5,724 | 59,308 | +24.8% |
| Net Margin | 13.3% | 27.8% | 22.4% | 29.0% | 27.8% | 19.4% | 4.4% | 32.1% |
Ownership & directors from companyinfo.ge (public corporate registry).